Zandelisib (Standard)

Overview

Zandelisib (Standard) is the analytical standard of Zandelisib ( HY-109198 ). This product is intended for research and analytical applications. Zandelisib (ME-401) is a selective, orally active, non-covalent inhibitor of PI3Kδ . Zandelisib can sustainably inhibit AKT phosphorylation and downstream signaling pathways. Zandelisib can be used in the study of malignancies such as relapsed/refractory B-cell lymphoma.

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > PI3K | Products > Signaling Pathways > Akt

Product Information

• Catalog No.: HY-109198R
• CAS No.: 1401436-95-0
• Molecular Formula: C31H38F2N8O
• Molecular Weight: 576.68
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source